- Home
- LCFY vs PHIO Comparison
LCFY vs PHIO Comparison
Compare LCFY & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- PHIO
- Stock Information
- Founded
- LCFY 2009
- PHIO 2011
- Country
- LCFY Australia
- PHIO United States
- Employees
- LCFY N/A
- PHIO N/A
- Industry
- LCFY
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- PHIO Health Care
- Exchange
- LCFY Nasdaq
- PHIO Nasdaq
- Market Cap
- LCFY 9.9M
- PHIO 8.0M
- IPO Year
- LCFY 2022
- PHIO N/A
- Fundamental
- Price
- LCFY $8.40
- PHIO $1.67
- Analyst Decision
- LCFY
- PHIO Strong Buy
- Analyst Count
- LCFY 0
- PHIO 1
- Target Price
- LCFY N/A
- PHIO $36.00
- AVG Volume (30 Days)
- LCFY 18.2K
- PHIO 981.0K
- Earning Date
- LCFY 04-01-2025
- PHIO 04-01-2025
- Dividend Yield
- LCFY N/A
- PHIO N/A
- EPS Growth
- LCFY N/A
- PHIO N/A
- EPS
- LCFY N/A
- PHIO N/A
- Revenue
- LCFY $2,668,385.00
- PHIO N/A
- Revenue This Year
- LCFY N/A
- PHIO N/A
- Revenue Next Year
- LCFY N/A
- PHIO N/A
- P/E Ratio
- LCFY N/A
- PHIO N/A
- Revenue Growth
- LCFY N/A
- PHIO N/A
- 52 Week Low
- LCFY $2.20
- PHIO $1.53
- 52 Week High
- LCFY $11.23
- PHIO $10.35
- Technical
- Relative Strength Index (RSI)
- LCFY 57.38
- PHIO 42.10
- Support Level
- LCFY $5.80
- PHIO $1.64
- Resistance Level
- LCFY $8.95
- PHIO $1.88
- Average True Range (ATR)
- LCFY 0.63
- PHIO 0.13
- MACD
- LCFY 0.13
- PHIO -0.02
- Stochastic Oscillator
- LCFY 82.54
- PHIO 5.61
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.